articleTop 1% cited
Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031
Leukemia · 2014 · Vol. 28(7) · pp. 1467–1471
Kirk R. Schultz✉(University of British Columbia)Andrew J. Carroll(University of Alabama at Birmingham)Nyla A. Heerema(The Ohio State University)W. Paul Bowman(Cook Children's Medical Center)Alexander Aledo(Cornell University)William B. Slayton(University of Florida Health)Harland N. Sather(University of Southern California)Meenakshi Devidas(Children's Oncology Group)Hao Zheng(Children's Hospital Colorado)Stella M. Davies(Cincinnati Children's Hospital Medical Center)Paul S. Gaynon(Children's Hospital of Los Angeles)ME Trigg(Thomas Jefferson University)R. Rutledge(Nova Scotia Cancer Centre)Dean Jorstad(Children's Hospital of Wisconsin)Naomi Winick(Southwestern Medical Center)Michael J. Borowitz(Johns Hopkins Hospital)Stephen P. Hunger(Children's Hospital Colorado)William L. Carroll(NYU Langone Health)Bruce M. Camitta(Children's Hospital of Wisconsin)from the Children’s Oncology Group
Acute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsHematopoietic Stem Cell TransplantationMedicineMinimal residual diseaseImatinibInternal medicineChemotherapyCohortImatinib mesylateAcute lymphocytic leukemiaOncologyInduction chemotherapy
MeSH terms
Imatinib MesylateAdolescentAntineoplastic AgentsBenzamidesChildChild, PreschoolChromosome AberrationsFollow-Up StudiesHumansInfantPiperazinesPrognosisPyrimidinesRecurrenceRemission Induction
Citations
443
FWCI
45.61
field-weighted impact
References
19
Percentile
100%
vs. same field & year
Citations per year
References
Nonparametric Estimation from Incomplete Observations
Journal of the American Statistical Association · 1958 · 38,793 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.